Testing the Synergy of Veliparib and Immune Checkpoint Inhibitors in Treatment of Urothelial Carcinoma

Project: Research project

Project Details


The primary goal of the project is to determine the combined response of urothelial carcinoma
to Veliparib and anti-PD-1/PD-L1 therapy.
Effective start/end date9/29/179/29/19


  • AbbVie Inc. (Agmt 9/29/17)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.